PapersFlow Research Brief
Mitochondrial Function and Pathology
Research Guide
What is Mitochondrial Function and Pathology?
Mitochondrial function and pathology encompasses the dynamics of mitochondria, including production and regulation of reactive oxygen species (ROS), mitochondrial fusion and fission, oxidative stress, mitochondrial dysfunction, and their roles in processes such as aging, neurodegenerative diseases, metabolic regulation, and cell death.
This field includes 156,863 papers on mitochondrial dynamics, ROS production, and implications in aging and neurodegenerative diseases. Key topics cover mitochondrial fusion and fission, oxidative stress, and mitochondrial contributions to cell death. Research examines superoxide as the proximal mitochondrial ROS produced at specific sites, influencing oxidative damage and redox signaling.
Topic Hierarchy
Research Sub-Topics
Mitochondrial Fusion and Fission
This sub-topic examines the molecular mechanisms regulating mitochondrial dynamics, including proteins like Drp1, Mfn1/2, and their roles in cellular health. Researchers study dysregulation in diseases using imaging and genetic models.
Mitochondrial Reactive Oxygen Species Production
This sub-topic investigates sites and regulation of ROS generation within mitochondria, including electron transport chain contributions. Researchers explore antioxidants and signaling functions of ROS.
Mitochondrial Dysfunction in Aging
This sub-topic analyzes how mtDNA mutations, bioenergetic decline, and proteostasis failure contribute to aging processes. Researchers link these to hallmarks of aging via model organisms.
Mitochondria in Neurodegenerative Diseases
This sub-topic studies mitochondrial impairments in Parkinson's, Alzheimer's, and ALS, focusing on transport, calcium handling, and mitophagy. Researchers use patient-derived models and biomarkers.
Mitochondria and Apoptosis
This sub-topic explores the intrinsic pathway where mitochondrial outer membrane permeabilization releases cytochrome c to initiate cell death. Researchers investigate Bcl-2 family regulators and therapeutic modulation.
Why It Matters
Mitochondrial dysfunction underlies pathologies like aging, as outlined in "The Hallmarks of Aging" by López-Otín et al. (2013), which links it to cellular senescence with 14,176 citations. In apoptosis, mitochondria release cytochrome c and exhibit transmembrane potential loss, as detailed in "Mitochondria and Apoptosis" by Green and Reed (1998) with 8,952 citations. ROS production by mitochondria drives diabetic complications via oxidative stress, per Brownlee (2001) in "Biochemistry and molecular cell biology of diabetic complications" (8,895 citations), and contributes to Parkinson's disease, where NRG Therapeutics raised $67 million targeting mitochondrial permeability transition pore inhibition (2025 news). Recent preclinical data on GT-02287 from Gain Therapeutics shows improved mitochondrial function by enhancing GCase trafficking, presented at a 2025 conference.
Reading Guide
Where to Start
"How mitochondria produce reactive oxygen species" by Murphy (2008) is the starting point for beginners, as it clearly explains ROS production sites and their pathological and signaling roles, foundational to understanding mitochondrial pathology.
Key Papers Explained
"Mitochondria and Apoptosis" by Green and Reed (1998) establishes mitochondria's central role in cytochrome c release and potential loss during cell death. This builds into aging contexts in "The Hallmarks of Aging" by López-Otín et al. (2013), linking mitochondrial dysfunction to senescence. Murphy (2008) in "How mitochondria produce reactive oxygen species" details superoxide generation underlying these processes, while Brownlee (2001) in "Biochemistry and molecular cell biology of diabetic complications" applies it to metabolic diseases.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints focus on mitophagy machinery in disease management, pathogen-induced mitochondrial disruption, and mitochondrial roles in cardiovascular diseases. News highlights therapeutics like NRG's mPTP inhibitor for Parkinson's ($67M raised) and GT-02287 for mitochondrial function in neurodegeneration.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Rat Brain in Stereotaxic Coordinates | 1982 | Elsevier eBooks | 52.3K | ✕ |
| 2 | The Hallmarks of Aging | 2013 | Cell | 14.2K | ✓ |
| 3 | Estimation of the number of nucleotide substitutions in the co... | 1993 | Molecular Biology and ... | 11.3K | ✓ |
| 4 | Sequence and organization of the human mitochondrial genome | 1981 | Nature | 9.6K | ✕ |
| 5 | Identification of programmed cell death in situ via specific l... | 1992 | The Journal of Cell Bi... | 9.5K | ✓ |
| 6 | Tandem repeats finder: a program to analyze DNA sequences | 1999 | Nucleic Acids Research | 9.3K | ✕ |
| 7 | Mitochondria and Apoptosis | 1998 | Science | 9.0K | ✕ |
| 8 | Biochemistry and molecular cell biology of diabetic complications | 2001 | Nature | 8.9K | ✕ |
| 9 | How mitochondria produce reactive oxygen species | 2008 | Biochemical Journal | 7.8K | ✓ |
| 10 | Preconditioning with ischemia: a delay of lethal cell injury i... | 1986 | Circulation | 7.8K | ✓ |
In the News
Oversubscribed £50m Series B led by SV Health Investors ...
NRG has identified a novel regulator of the mitochondrial permeability transition pore (mPTP) which is essential for pore opening and amenable to small molecule inhibition. This breakthrough has en...
Gain Therapeutics Presents Preclinical GT-02287 Data at ...
These findings together suggest that GT-02287 improves mitochondrial function by facilitating GCase trafficking to the mitochondria.
M&A in mitochondrial therapies: New opportunities in rare ...
_In this week’s Expert View, Dr Cheryl Barton examines how mitochondrial therapeutics are moving from the margins of rare disease into the mainstream of drug development. Investor appetite is retur...
NRG raises $67 million for a small molecule for Parkinson's ...
That approach is to tackle neurodegenerative diseases like Parkinson’s disease and amyotrophic lateral sclerosis (ALS) by fixing mitochondrial dysfunction, a pathology that Miller says is common to...
Breaking Barriers in Mitochondrial Disease Treatment
(Getty Images)This article explores the challenges, breakthroughs, and emerging therapies in mitochondrial diseases, with a particular focus on TK2d.
Code & Tools
This is a mechanistic model of myocardial mitochondrial metabolism including oxidative phosphorylation,$\\beta$-oxidation, TCA cycle, metaboilte tr...
Python-based pipeline for the tracking, visualization, and analysis of 4D mitochondrial network data pylattice.github.io/MitoTNT/ ### License BS...
MitoX is a python package for the analysis of mitochondrial variants from both bulk and single cell RNA-seq and ATAC-seq data.
## Repository files navigation # MitoReport Unit Tests Mitoreport is an application for Mitochondrial DNA variants analysis. ## Prerequisites
## Repository files navigation mity logo # mity `mity` is a bioinformatic analysis pipeline designed to call mitochondrial SNV and INDEL varia...
Recent Preprints
Mitochondrial Diseases: Molecular Pathogenesis and ...
Mitochondrial diseases are a heterogeneous group of inherited disorders caused by pathogenic variants in mitochondrial DNA (mtDNA) or nuclear genes encoding mitochondrial proteins, culminating in d...
Pathogen-induced mitochondrial dysfunction: mechanistic ...
Mitochondria have emerged as multifunctional organelles central to cellular metabolism, innate immunity, and cell fate determination. Increasing evidence demonstrates that pathogens-including virus...
Mitophagy in the pathogenesis and management of disease
Mitophagy, an evolutionarily conserved quality-control process, selectively removes damaged mitochondria to maintain cellular homeostasis. Recent advances in our understanding of the molecular mach...
Advances in Mitochondrial Dysfunction and Its Role ...
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide and is attributed to complex pathophysiological mechanisms that surpass the traditional risk factors. Em...
Overview of methods that determine mitochondrial function in human disease
combination of techniques such as respirometry, which remains the gold standard, and assessing mitochondrial membrane potential (MMP) can help elucidate mitochondrial function and dysfunction. 2. O...
Latest Developments
Recent developments in mitochondrial research as of February 2026 include advancements in understanding mitochondrial signaling in physiology and disease, with conferences such as the Keystone Symposia focusing on this area (keystonesymposia.org), and ongoing investigations into mitochondrial roles in aging, including potential rejuvenation strategies involving healthy mitochondrial replacement (PMC). Additionally, studies have explored mitochondrial quality control mechanisms, such as the identification of MISO's role in mitochondrial dynamics and degradation (nature.com), and structural insights into mitochondrial calcium transporters (nature.com).
Sources
Frequently Asked Questions
What is the primary ROS produced by mitochondria?
Superoxide (O2•−) is the proximal mitochondrial ROS. It is generated at specific sites within the organelle and contributes to oxidative damage in pathologies while enabling retrograde redox signaling to the cytosol and nucleus. This is detailed in "How mitochondria produce reactive oxygen species" by Murphy (2008).
How do mitochondria contribute to apoptosis?
Mitochondria release caspase activators like cytochrome c, undergo changes in electron transport, lose transmembrane potential, and alter cellular oxidation-reduction during apoptosis. Pro- and antiapoptotic Bcl-2 family members regulate these events. "Mitochondria and Apoptosis" by Green and Reed (1998) identifies these key mitochondrial roles.
What role does mitochondrial dysfunction play in aging?
Mitochondrial dysfunction is one of the hallmarks of aging, involving impaired bioenergetics and increased oxidative stress. It contributes to cellular damage accumulation over time. "The Hallmarks of Aging" by López-Otín et al. (2013) establishes this connection.
How is mitochondrial DNA substitution estimated?
A mathematical method estimates transitional and transversional substitutions per site in the control region of mitochondrial DNA. It was developed by analyzing patterns in humans and chimpanzees. Tamura and Nei (1993) introduced this in "Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees.".
What methods assess mitochondrial function in human disease?
Respirometry serves as the gold standard, often combined with mitochondrial membrane potential assessment. These techniques elucidate function and dysfunction in pathology. A recent overview (2025 preprint) highlights their combined use.
Open Research Questions
- ? How do heteroplasmy-driven threshold effects precisely determine the onset of multisystem involvement in mitochondrial diseases?
- ? What are the exact mechanisms by which pathogens target mitochondrial dynamics to reprogram host metabolism and evade immunity?
- ? How does the molecular machinery of mitophagy respond to specific stress triggers to selectively degrade damaged mitochondria?
- ? In what ways does mitochondrial dysfunction link oxidative stress imbalance to cardiovascular disease progression beyond traditional risk factors?
- ? Can small molecule inhibition of the mitochondrial permeability transition pore regulators fully restore function in neurodegenerative diseases like Parkinson's?
Recent Trends
Field has 156,863 works with sustained interest in mitochondrial diseases from heteroplasmy and ROS excess (recent preprint).
Preprints emphasize mitophagy in pathogenesis, pathogen targeting of dynamics, and CVD links, while 2025 news reports NRG Therapeutics' $67M funding for mPTP inhibitors in Parkinson's/ALS and Gain Therapeutics' GT-02287 data improving GCase trafficking to mitochondria.
Research Mitochondrial Function and Pathology with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mitochondrial Function and Pathology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers